Heidi L. Smith

654 total citations
23 papers, 258 citations indexed

About

Heidi L. Smith is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Heidi L. Smith has authored 23 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Heidi L. Smith's work include Parasitic Diseases Research and Treatment (6 papers), Parasite Biology and Host Interactions (3 papers) and Hepatitis C virus research (3 papers). Heidi L. Smith is often cited by papers focused on Parasitic Diseases Research and Treatment (6 papers), Parasite Biology and Host Interactions (3 papers) and Hepatitis C virus research (3 papers). Heidi L. Smith collaborates with scholars based in United States, Australia and Canada. Heidi L. Smith's co-authors include T. V. Rajan, Glenys Gibson, William C. Campbell, Subash Babu, A. M. Denman, Deborah C. Molrine, Peter Cheslock, Robin Thorpe, C.R. Bird and K. J. Jakeman and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Heidi L. Smith

20 papers receiving 243 citations

Peers

Heidi L. Smith

ECOLO

EPIDE

PHEOH

Laila Ahmed Egypt

Ashraf Said Egypt

Niluka Goonawardane United Kingdom

Iskak Koiman Nigeria

Reginald Coler United States

Kristoffer E. Leon United States

V. Vasuki India

Kazuhiro Okubo Japan

Katrin Gentil Germany

Maria J. Magalhães Portugal

Laila Ahmed Egypt

Heidi L. Smith

119 ×1.0

48 ×0.7

32 ×0.7

ECOLO

22 ×0.5

EPIDE

42 ×1.3

PHEOH

Citations per year, relative to Heidi L. Smith Heidi L. Smith (= 1×) peers Laila Ahmed

Countries citing papers authored by Heidi L. Smith

Since Specialization

Citations

This map shows the geographic impact of Heidi L. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi L. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi L. Smith more than expected).

Fields of papers citing papers by Heidi L. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi L. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi L. Smith. The network helps show where Heidi L. Smith may publish in the future.

Co-authorship network of co-authors of Heidi L. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi L. Smith. A scholar is included among the top collaborators of Heidi L. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi L. Smith. Heidi L. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smith, Heidi L., et al.. (2025). New directions in the multifunctionality of RNA viruses: insights from the rabies virus P-protein. Current Opinion in Virology. 73. 101496–101496.

Smith, Heidi L., Abhay Joshi, Daniel B. Rubin, et al.. (2024). Regulatory Considerations in the Approval of Rezafungin (Rezzayo) for the Treatment of Candidemia and Invasive Candidiasis in Adults. The Journal of Infectious Diseases. 230(2). 505–513. 11 indexed citations

Smith, Heidi L., Deri Morgan, Kiersten L. Berggren, et al.. (2020). The MAPKAPK2 Pathway Mediates Radiation-Induced Tumor Inflammation And Proliferation In Bladder Cancer. International Journal of Radiation Oncology*Biology*Physics. 108(3). e537–e538.

Smith, Heidi L., et al.. (2017). Characterization of serum anti-diphtheria antibody activity following administration of equine anti-toxin for suspected diphtheria. Human Vaccines & Immunotherapeutics. 13(11). 2738–2741. 3 indexed citations

Smith, Heidi L., Raymond T. Chung, Parvez Mantry, et al.. (2016). Prevention of allograft HCV recurrence with peri‐transplant human monoclonal antibody MBL‐HCV1 combined with a single oral direct‐acting antiviral: A proof‐of‐concept study. Journal of Viral Hepatitis. 24(3). 197–206. 9 indexed citations

Smith, Heidi L., Peter Cheslock, Mark D. Leney, Bruce Barton, & Deborah C. Molrine. (2016). Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria anti-toxin in a guinea pig intoxication model. Virulence. 7(6). 660–668. 10 indexed citations

Babcock, Gregory J., Sowmya Iyer, Heidi L. Smith, et al.. (2014). High-Throughput Sequencing Analysis of Post-Liver Transplantation HCV E2 Glycoprotein Evolution in the Presence and Absence of Neutralizing Monoclonal Antibody. PLoS ONE. 9(6). e100325–e100325. 18 indexed citations

Smith, Heidi L., Thomas P. Monath, Pamela Pazoles, et al.. (2011). Development of Antigen-Specific Memory CD8+ T Cells Following Live-Attenuated Chimeric West Nile Virus Vaccination. The Journal of Infectious Diseases. 203(4). 513–522. 20 indexed citations

Williamson, Stephen K., Chung-Tsen Hsueh, Andrew R. Allen, et al.. (2008). PDGFR inhibition using imatinib (I) combined with docetaxel (D), a potential new treatment strategy in the treatment of recurrent non-small cell lung cancer (NSCLC): Preliminary efficacy results. Journal of Clinical Oncology. 26(15_suppl). 19055–19055. 1 indexed citations

10.

Huang, Chao, Stephen K. Williamson, Peter J. Van Veldhuizen, et al.. (2007). Phase II trial of imatinib (I) and docetaxel (D) in recurrent non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 25(18_suppl). 18132–18132. 1 indexed citations

11.

Gibson, Glenys & Heidi L. Smith. (2004). From embryos to juveniles: morphogenesis in the spionid Boccardia proboscidea (Polychaeta). Invertebrate Biology. 123(2). 136–145. 12 indexed citations

12.

Smith, Heidi L. & T. V. Rajan. (2001). INHIBITORS OF THE LIPOXYGENASE PATHWAY BLOCK DEVELOPMENT OFBRUGIA MALAYIL3 IN VITRO. Journal of Parasitology. 87(2). 242–249. 7 indexed citations

13.

Smith, Heidi L., et al.. (2000). Development of a Serum-Free System for the in Vitro Cultivation of Brugia malayi Infective-Stage Larvae. Experimental Parasitology. 95(4). 253–264. 14 indexed citations

14.

Smith, Heidi L.. (2000). Investigating development of infective stage larvae of filarial nematodes. Frontiers in bioscience. 5(4). e95–102. 6 indexed citations

15.

Smith, Heidi L. & T. V. Rajan. (2000). Tetracycline Inhibits Development of the Infective-Stage Larvae of Filarial Nematodes in Vitro. Experimental Parasitology. 95(4). 265–270. 69 indexed citations

16.

Rajan, T. V., et al.. (1999). Life and Death of Brugia malayi in the Mammalian Host: Passive Death vs Active Killing. Experimental Parasitology. 93(2). 120–122. 7 indexed citations

17.

Smith, Heidi L. & Glenys Gibson. (1999). Nurse egg origin in the polychaeteBoccardia proboscidea(Spionidae). Invertebrate Reproduction & Development. 35(3). 177–185. 19 indexed citations

18.

Daley, Denise A, et al.. (1996). An evaluation of the in vitro activity of piperacillin/tazobactam. Pathology. 28(2). 167–172. 11 indexed citations

19.

Jakeman, K. J., C.R. Bird, Robin Thorpe, Heidi L. Smith, & C. Sweet. (1991). Nature of the endogenous pyrogen (EP) induced by influenza viruses: lack of correlation between EP levels and content of the known pyrogenic cytokines, interleukin 1, interleukin 6 and tumour necrosis factor. Journal of General Virology. 72(3). 705–709. 14 indexed citations

20.

Smith, Heidi L. & A. M. Denman. (1978). A new manifestation of infection with Epstein-Barr virus.. BMJ. 2(6132). 248.1–248. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact